3-186672838-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000412.5(HRG):​c.610C>T​(p.Pro204Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.359 in 1,606,904 control chromosomes in the GnomAD database, including 109,148 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.43 ( 14941 hom., cov: 32)
Exomes 𝑓: 0.35 ( 94207 hom. )

Consequence

HRG
NM_000412.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.14

Publications

54 publications found
Variant links:
Genes affected
HRG (HGNC:5181): (histidine rich glycoprotein) This histidine-rich glycoprotein contains two cystatin-like domains and is located in plasma and platelets. The physiological function has not been determined but it is known that the protein binds heme, dyes and divalent metal ions. The encoded protein also has a peptide that displays antimicrobial activity against C. albicans, E. coli, S. aureus, P. aeruginosa, and E. faecalis. It can inhibit rosette formation and interacts with heparin, thrombospondin and plasminogen. Two of the protein's effects, the inhibition of fibrinolysis and the reduction of inhibition of coagulation, indicate a potential prothrombotic effect. Mutations in this gene lead to thrombophilia due to abnormal histidine-rich glycoprotein levels. [provided by RefSeq, Nov 2014]
HRG-AS1 (HGNC:55915): (HRG and FETUB antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.45819E-5).
BP6
Variant 3-186672838-C-T is Benign according to our data. Variant chr3-186672838-C-T is described in ClinVar as Benign. ClinVar VariationId is 1285353.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.588 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HRGNM_000412.5 linkc.610C>T p.Pro204Ser missense_variant Exon 5 of 7 ENST00000232003.5 NP_000403.1 P04196
HRGXM_005247415.5 linkc.610C>T p.Pro204Ser missense_variant Exon 5 of 7 XP_005247472.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HRGENST00000232003.5 linkc.610C>T p.Pro204Ser missense_variant Exon 5 of 7 1 NM_000412.5 ENSP00000232003.4 P04196

Frequencies

GnomAD3 genomes
AF:
0.426
AC:
64693
AN:
151790
Hom.:
14924
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.594
Gnomad AMI
AF:
0.461
Gnomad AMR
AF:
0.418
Gnomad ASJ
AF:
0.386
Gnomad EAS
AF:
0.557
Gnomad SAS
AF:
0.457
Gnomad FIN
AF:
0.284
Gnomad MID
AF:
0.472
Gnomad NFE
AF:
0.337
Gnomad OTH
AF:
0.418
GnomAD2 exomes
AF:
0.382
AC:
95937
AN:
251218
AF XY:
0.380
show subpopulations
Gnomad AFR exome
AF:
0.604
Gnomad AMR exome
AF:
0.347
Gnomad ASJ exome
AF:
0.391
Gnomad EAS exome
AF:
0.548
Gnomad FIN exome
AF:
0.274
Gnomad NFE exome
AF:
0.335
Gnomad OTH exome
AF:
0.369
GnomAD4 exome
AF:
0.352
AC:
512853
AN:
1454996
Hom.:
94207
Cov.:
31
AF XY:
0.355
AC XY:
256927
AN XY:
724144
show subpopulations
African (AFR)
AF:
0.615
AC:
20490
AN:
33312
American (AMR)
AF:
0.352
AC:
15715
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.394
AC:
10288
AN:
26096
East Asian (EAS)
AF:
0.511
AC:
20268
AN:
39660
South Asian (SAS)
AF:
0.447
AC:
38489
AN:
86080
European-Finnish (FIN)
AF:
0.277
AC:
14815
AN:
53406
Middle Eastern (MID)
AF:
0.451
AC:
2596
AN:
5752
European-Non Finnish (NFE)
AF:
0.332
AC:
367011
AN:
1105810
Other (OTH)
AF:
0.385
AC:
23181
AN:
60178
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
14939
29879
44818
59758
74697
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11976
23952
35928
47904
59880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.426
AC:
64754
AN:
151908
Hom.:
14941
Cov.:
32
AF XY:
0.426
AC XY:
31619
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.594
AC:
24619
AN:
41424
American (AMR)
AF:
0.418
AC:
6380
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.386
AC:
1339
AN:
3468
East Asian (EAS)
AF:
0.557
AC:
2876
AN:
5162
South Asian (SAS)
AF:
0.457
AC:
2200
AN:
4812
European-Finnish (FIN)
AF:
0.284
AC:
2995
AN:
10540
Middle Eastern (MID)
AF:
0.469
AC:
138
AN:
294
European-Non Finnish (NFE)
AF:
0.337
AC:
22917
AN:
67938
Other (OTH)
AF:
0.415
AC:
872
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1825
3651
5476
7302
9127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
590
1180
1770
2360
2950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.370
Hom.:
52660
Bravo
AF:
0.440
TwinsUK
AF:
0.330
AC:
1225
ALSPAC
AF:
0.336
AC:
1296
ESP6500AA
AF:
0.594
AC:
2615
ESP6500EA
AF:
0.342
AC:
2945
ExAC
AF:
0.385
AC:
46787
Asia WGS
AF:
0.489
AC:
1700
AN:
3478
EpiCase
AF:
0.352
EpiControl
AF:
0.349

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

HRG-related disorder Benign:1
Sep 24, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.053
BayesDel_addAF
Benign
-0.75
T
BayesDel_noAF
Benign
-0.71
CADD
Benign
12
DANN
Benign
0.13
DEOGEN2
Benign
0.066
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.0089
N
LIST_S2
Benign
0.23
T
MetaRNN
Benign
0.000065
T
MetaSVM
Benign
-0.95
T
MutationAssessor
Benign
-2.5
N
PhyloP100
2.1
PrimateAI
Benign
0.39
T
PROVEAN
Benign
3.0
N
REVEL
Benign
0.080
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.065
MPC
0.077
ClinPred
0.0022
T
GERP RS
4.3
Varity_R
0.023
gMVP
0.16
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9898; hg19: chr3-186390627; COSMIC: COSV51643774; COSMIC: COSV51643774; API